Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06762262

Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients

Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their breathing technique. Often patients with hypertension seek various treatments to relieve symptoms. The aim of this study is to compare the effects of Pilates Training and Moderate Intensity Continuous Training on dyspnea and cardiovascular fitness in hypertensive patients. The study would be randomized clinical trial. A total of thirty-four subjects will be assigned randomly by using block randomization into two groups. Group A will be given Pilates training while Group B will moderate intensity training. After confirmation of diagnosis with medical history and physical examination as well as chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP]between 90-109 mm Hg) recommended. 3-minute step test, VO2max and Modified BORG scale would be used as an outcome measure tools for cardiovascular parameters and dyspnea. The collected data will be analyzed in SPSS 25.0. Descriptive and inferential statistics will be applied after testing normality of data

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sheikh Zaid Hospital

Quetta, Balochistan, oooo, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be between 45 to 70 years old
  • Gender: Male and Female both
  • Chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure
  • [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP] between 90-109 mm Hg).
  • Single antihypertensive medication will be recruited.
  • Participants have sedentary life style.
  • Smokers, alcoholic, diabetic, and other cardiac problems (controlled) would be included.

Exclusion criteria

  • Patients with Permanent atrial fibrillation
  • Patients with COPD
  • Patients with Heart surgery
  • Patients with presence of symptomatic congestive heart failure
  • Smokers, alcoholic, diabetic, and other cardiac, renal, and respiratory disease patients (uncontrolled) would be excluded.
  • Participants with no history of psychiatry or psychological disorders or abnormalities.

Treatment and study plan

Moderate-Intensity continuous training

Combination Product

refers to a type of aerobic exercise that involves maintaining a steady and moderate level of physical activity for an extended period. The exercise is performed at a consistent and moderate pace without significant fluctuations in intensity. MICT primarily targets the aerobic energy system, enhancing cardiovascular endurance and respiratory efficiency

Primary outcomes

  1. 6 MWT

    Time frame: 8 weeks

  2. VO2 max

    Time frame: 8 weeks

  3. Borg Dyspnea Scale

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Pilate Training Versus Moderate Intensity Continous Training on Dyspnea and Cardiovascular Fitness in Hypertensive Patients

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Jan 7, 2025
Registry last updated
Jan 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.